Compare Agilent Technologies Inc (A) vs Snap Inc (SNAP) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Snap Inc — how do they compare? Agilent Technologies Inc trades at $128.38 (market cap $37.04B), while Snap Inc trades at $4.55 (market cap $7.71B). The key difference: Agilent Technologies Inc is far larger — about 4.8× Snap Inc's market cap, and Agilent Technologies Inc pays a 0.78% dividend while Snap Inc pays none. Which is the better fit depends on your goals.
| A | SNAP | |
|---|---|---|
Market Cap | $37.04B | $7.71B |
Sector | Health | Media |
52-Week High | $157.20 | $10.35 |
52-Week Low | $110.24 | $3.93 |
Enterprise Value | $38.59B | $9.08B |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Snap Inc. (SNAP) trades at $4.65, down 4.12% on the day, reflecting investor concerns over its recent launch of high-priced AR glasses. The stock shows a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, revenue grew to $5.93 billion in 2025, yet the company remains unprofitable with a net loss of $460 million. Analyst sentiment is cautious, with a consensus price target of $7.22 but a majority hold rating.
Snap's outlook hinges on monetizing its augmented reality initiatives and achieving sustained user growth, but execution risks and competitive pressures from larger peers like Meta pose significant challenges. The stock offers speculative upside if new hardware gains traction, yet persistent losses and regulatory scrutiny over social media safety present substantial downside risks for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →
